Correlation Between Palisade Bio and Transcode Therapeutics
Can any of the company-specific risk be diversified away by investing in both Palisade Bio and Transcode Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Palisade Bio and Transcode Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Palisade Bio and Transcode Therapeutics, you can compare the effects of market volatilities on Palisade Bio and Transcode Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Palisade Bio with a short position of Transcode Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Palisade Bio and Transcode Therapeutics.
Diversification Opportunities for Palisade Bio and Transcode Therapeutics
0.09 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Palisade and Transcode is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Palisade Bio and Transcode Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Transcode Therapeutics and Palisade Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Palisade Bio are associated (or correlated) with Transcode Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Transcode Therapeutics has no effect on the direction of Palisade Bio i.e., Palisade Bio and Transcode Therapeutics go up and down completely randomly.
Pair Corralation between Palisade Bio and Transcode Therapeutics
Given the investment horizon of 90 days Palisade Bio is expected to generate 0.68 times more return on investment than Transcode Therapeutics. However, Palisade Bio is 1.48 times less risky than Transcode Therapeutics. It trades about -0.11 of its potential returns per unit of risk. Transcode Therapeutics is currently generating about -0.08 per unit of risk. If you would invest 240.00 in Palisade Bio on December 1, 2024 and sell it today you would lose (157.00) from holding Palisade Bio or give up 65.42% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Palisade Bio vs. Transcode Therapeutics
Performance |
Timeline |
Palisade Bio |
Transcode Therapeutics |
Palisade Bio and Transcode Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Palisade Bio and Transcode Therapeutics
The main advantage of trading using opposite Palisade Bio and Transcode Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Palisade Bio position performs unexpectedly, Transcode Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Transcode Therapeutics will offset losses from the drop in Transcode Therapeutics' long position.Palisade Bio vs. Zura Bio Limited | Palisade Bio vs. Immix Biopharma | Palisade Bio vs. Enveric Biosciences | Palisade Bio vs. ZyVersa Therapeutics |
Transcode Therapeutics vs. Xenetic Biosciences | Transcode Therapeutics vs. Reviva Pharmaceuticals Holdings | Transcode Therapeutics vs. Eyenovia | Transcode Therapeutics vs. Cognition Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |